Judge: Investors Failed To Plead Misrepresentation, Scienter In Securities Suit
(July 14, 2016, 11:35 PM EDT) -- NEW YORK — A federal judge in New York on July 6 dismissed a second amended complaint filed against the former CEO of an Australian drug company, ruling that lead plaintiffs failed to plead an actionable misrepresentation and scienter in making their federal securities law claims (Marsha Gillis, et al. v. QRX Pharma Ltd., et al., No. 15-4868, S.D. N.Y.; 2016 U.S. Dist. LEXIS 87489).
(Opinion available. Document #57-160718-017Z.)
Shareholder Robert Burns Logan sued QRX Pharma Ltd. and its former CEO, John Holaday, in the U.S....